“…So far, the Pathogen Box has been screened against the nematode H. contortus ( Preston et al, 2016 ), the fungi Candida albicans and Cryptococcus neoformans ( Vila and Lopez-Ribot, 2016 ; Mayer and Kronstad, 2017 ), Plasmodium and the kinetoplastids Leishmania and Trypanosoma ( Calit et al, 2018 ; Dennis et al, 2018 ; Duffy et al, 2017 ), Neospora caninum ( Müller et al, 2017 ) , Mycobacterium abscessus and M. avium ( Jeong et al, 2018 ; Low et al, 2017 ), Toxoplasma gondii ( Spalenka et al, 2017 ), C. elegans ( Partridge et al, 2018 ), Entamoeba histolytica ( Mi-Ichi et al, 2018 ), and Giardia lamblia and Cryptosporidium parvum ( Hennessey et al, 2018 ). Interestingly, all compounds that exhibited activity against E. multilocularis were also active against at least one more pathogen other than the one it was selected for by MMV (with the exception of nitazoxanide), thus underlining the importance and potential of the concept of drug repurposing.…”